Clinical Trials
2 trialsNCT06896890 2025-03-26
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Inhatarget Therapeutics
Phase 1/2 Recruiting
NCT00210080 2015-09-04
A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)
Merck Sharp & Dohme LLC
Phase 3 Completed